CRISPR QC Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
CRISPR QC General Information
Description
Developer of an analytics platform designed to simulate the gene editing process before introduction to cells. The company's platform provides key cornerstones of information and insight fundamental to realizing the full potential and quality control for clustered regularly interspaced short palindromic repeats gene editing, enabling scientists to increase editing efficiency and define a strategy to achieve better outcomes at the cellular level.
Contact Information
Website
www.crisprqc.comCorporate Office
- 6191 Cornerstone Court E
- Suite 113
- San Diego, CA 92121
- United States
Corporate Office
- 6191 Cornerstone Court E
- Suite 113
- San Diego, CA 92121
- United States
CRISPR QC Timeline
CRISPR QC Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Early Stage VC (Series A1) | 02-Apr-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 11-Jan-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 16-Aug-2022 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 05-Apr-2022 | Completed | Generating Revenue |
CRISPR QC Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 | ||||||||
| Seed | 2,283,892 | $0.000100 | $0.71 | $0.71 | 1x | $0.71 | 10.36% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CRISPR QC Signals
CRISPR QC Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biobrit | Venture Capital | Minority | ||
| Keiretsu Forum | Angel Group | Minority | ||
| Suncoast Ventures | Venture Capital | Minority | ||
| Xcellerant Ventures | Venture Capital | Minority | ||
| BioTools Innovator | Accelerator/Incubator | Minority |
CRISPR QC FAQs
-
When was CRISPR QC founded?
CRISPR QC was founded in 2021.
-
Where is CRISPR QC headquartered?
CRISPR QC is headquartered in San Diego, CA.
-
What is the size of CRISPR QC?
CRISPR QC has 12 total employees.
-
What industry is CRISPR QC in?
CRISPR QC’s primary industry is Other Healthcare Technology Systems.
-
Is CRISPR QC a private or public company?
CRISPR QC is a Private company.
-
What is CRISPR QC’s current revenue?
The current revenue for CRISPR QC is .
-
How much funding has CRISPR QC raised over time?
CRISPR QC has raised $11.6M.
-
Who are CRISPR QC’s investors?
Biobrit, Keiretsu Forum, Suncoast Ventures, Xcellerant Ventures, and BioTools Innovator are 5 of 10 investors who have invested in CRISPR QC.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process